Treatment of acute attacks of hereditary angioedema due to C1 inhibitor deficiency with icatibant in paediatric versus adult patients: Findings from the icatibant outcome survey

被引：0
|
作者：
Longhurst, H. J. [1 ,2 ]
Bouillet, L. [3 ]
Aberer, W. [4 ]
Caballero, T. [5 ]
Grumach, A. S. [6 ]
Botha, J. [7 ]
Andresen, I [7 ]
Maurer, M. [8 ]
机构：
[1] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England
[2] Univ Coll London Hosp, London, England
[3] Grenoble Univ, Dept Internal Med, Natl Reference Ctr Angioedema, Grenoble, France
[4] Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria
[5] Hosp La Paz, Inst Hlth Res IdiPaz, Biomed Res Network Rare Dis CIBERER, Dept Allergy,U754, Madrid, Spain
[6] Univ Ctr Hlth ABC, Sch Med, Clin Immunol, Santo Andre, SP, Brazil
[7] Shire, Zug, Switzerland
[8] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergie Ctr Charite, Dermatol Allergol, Berlin, Germany
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1333
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [41] Hereditary angioedema with normal C1 inhibitor in a French cohort: clinical characteristics and response to treatment with icatibant
    Bouillet, L.
    Boccon-Gibod, I
    Launay, D.
    Gompel, A.
    Kanny, G.
    Fabien, V
    Fain, O.
    [J]. ALLERGY, 2014, 69 : 52 - 53
  • [42] Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
    Zanichelli, Andrea
    Magerl, Markus
    Longhurst, Hilary J.
    Aberer, Werner
    Caballero, Teresa
    Bouillet, Laurence
    Bygum, Anette
    Grumach, Anete S.
    Botha, Jaco
    Andresen, Irmgard
    Maurer, Marcus
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2018, 8
  • [43] Patients' preference for self-administered icatibant treatment of acute hereditary angioedema attacks
    Maurer, M.
    Malbran, A.
    Aberer, W.
    Wiednig, M.
    Reshef, A.
    Nair, N.
    Lachmann, A.
    Hoch, B.
    Bloom, B.
    Longhurst, H.
    Kivity, S.
    [J]. ALLERGY, 2011, 66 : 425 - 425
  • [44] Daily circadian variability of angioedema attacks in patients with hereditary angioedema due to C1 inhibitor deficiency
    Villani, L.
    Perego, F.
    Zanichelli, A.
    Wu, M.
    Cicardi, M.
    [J]. ALLERGY, 2016, 71 : 297 - 298
  • [45] Long-term effectiveness and safety of icatibant for the on-demand treatment of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey
    Maurer, M.
    Longhurst, H. J.
    Bouillet, L.
    Caballero, T.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Aberer, W.
    [J]. ALLERGY, 2020, 75 : 59 - 60
  • [46] Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
    Longhurst, H. J.
    Zanichelli, A.
    Caballero, T.
    Bouillet, L.
    Aberer, W.
    Maurer, M.
    Fain, O.
    Fabien, V.
    Andresen, I.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 188 (01): : 148 - 153
  • [47] A case series about the treatment of hereditary angioedema due to C1 inhibitor deficiency with icatibant, a selective bradykinin B2 receptor antagonist
    Bork, K.
    [J]. ALLERGY, 2010, 65 : 455 - 455
  • [48] Clinical experiences with Icatibant in patients with hereditary and acquired angioedema due to C1-INH-deficiency
    Magerl, M.
    Weller, K.
    Krause, K.
    Metz, M.
    Maurer, M.
    [J]. ALLERGY, 2010, 65 : 446 - 446
  • [49] SUCCESSFUL TREATMENT OF ACQUIRED C1 ESTERASE INHIBITOR DEFICIENCY WITH ICATIBANT
    Fu, L.
    Betschel, S.
    Binkley, K. E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A83 - A83
  • [50] Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study
    Grumach, Anete S.
    Henriques, Marina T.
    Bardou, Maine L. D.
    Pontarolli, Daniele A.
    Botha, Jaco
    Correa, Mariangela
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (04) : 448 - 457
12345